Nextel Medical Corp. MAJI
Set alert
0.00 USD 0.00 -16.67%
As of Nov 2, 12:22 PM ET
0.003 Day range 0.003
0.002 52-week range 0.088
- YTD
- -94.55%
- 1 year
- -96.47%
- Open
- 0.003
- Prev close
- 0.0036
- Mkt cap
- 268.08K
- Vol
- 100.00K
- Avg vol
- 559.38K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.003
- High
- 0.003
2Y chart
Signals (70)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| RSI: Oversold | Oct 9, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| RSI: Oversold | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 28, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 22, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | May 8, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 9, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 24, 2026 | 7 months ago |
Newest 20 of 70.
News
- NexTel Medical Corp. Announces Next-Generation Wellness Product Line Incorporating FDA-Approved Pharmaceuticals
- NexTel Medical Corp. Announces Strategic Joint Venture to Commercialize Breakthrough Patented Hair Regeneration Technology
- NexTel Medical Corp. Showcases Pioneer Exosome Technologies and Diagnostic Innovations at Leading Healthcare Conference
- NexTel Medical Corp. Clarifies and Expands Upon Remarks Made During Recent Online Discussion
- NexTel Medical Corp. Executes Letter of Intent to Acquire 100% of Xycota Biosciences, LLC
- NexTel Medical Corp. Advances Veterinary Oncology Strategy with Rollout of Early-Stage Cancer Screening for Companion Animals
- NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform
- NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome™ Commercialization
- NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist
- Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value
Your note
Sign in to keep a note on MAJI — it syncs with the Stock Master app.